Littoral Environnement et Sociétés (LIENSs), UMR 7266, CNRS-Université de La Rochelle, 2 Rue Olympe de Gouges, 17042, La Rochelle Cedex 01, France. tamas.malkocs@gmail.com.
Pál Juhász-Nagy Doctoral School of Biology and Environmental Sciences, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Biology and Ecology, University of Debrecen, Egyetem tér 1, 4032, Debrecen, Hungary. tamas.malkocs@gmail.com.
Institute of Aquatic Ecology, Centre for Ecological Research, 4026, Debrecen, Hungary. tamas.malkocs@gmail.com.
Ctedra Diversidad Animal I and Laboratorio de Virologa y Gentica Molecular; Facultad de Ciencias Naturales y Ciencias de la Salud; Universidad Nacional de la Patagonia San Juan Bosco; 9 de Julio y Belgrano s/n; 9100 Trelew; Chubut; ARGENTINA. jgloreley@gmail.com.
Museo Argentino de Ciencias Naturales Bernardino Rivadavia; Av. ngel Gallardo 470; C1405DJR Ciudad Autnoma de Buenos Aires; ARGENTINA. gpastorino@macn.gov.ar.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: gsmedley@iastate.edu.
Department of Zoology, University of São Paulo, Rua do Matão, Travessa 14, n. 101, 05508-090 São Paulo, SP, Brazil. Electronic address: jorgeaudino@ib.usp.br.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: courtney.grula@ndsu.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aporathk@umn.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: apairett@iastate.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: aalejand@whittier.edu.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: felicity.masters@research.usc.edu.au.
Faculty of Science, Health, Education, and Engineering, University of the Sunshine Coast, Maroochydore DC, Queensland 4558, Australia. Electronic address: pduncan@usc.edu.au.
Department of Invertebrate Zoology, National Museum of National History, Smithsonian Institution, 10th and Constitution Ave NW, Washington, DC 20560, USA. Electronic address: StrongE@si.edu.
Department of Evolution, Ecology, and Organismal Biology, Iowa State University, 2200 Osborn Dr, 251 Bessey Hall, Ames, IA 50011, USA. Electronic address: serb@iastate.edu.
Injectable biphasic ceramic bone substitutes (BCBSs) represent a modern alternative to conventional options for bone defect filling, as they further open the possibilities for percutaneous cavity reco...
Between 2013 and 2017, 18 patients were [1] treated with BCBS [2] for benign bone lesions and [3] had a complete set of retrospective information, including surgical protocols, imaging, patient dismis...
Local recurrence was reported in four patients. A distinctive bone remodelling pattern was noted on follow-up X-ray and magnetic resonance imaging showing a double-line phenomenon and continuously inc...
In a limited case series, the studied BCBS demonstrated acceptable surgical outcomes. Initial wound leakage and recurrence seemed to be associated with percutaneous injection. Further studies are need...
We examine the range of available bone graft substitutes often used in nonunion and malunion surgery of the upper extremity. Synthetic materials such as calcium sulfate, beta-calcium phosphate ceramic...
Male patients often experience increased bone and muscle loss after traumatic fractures. This study aims to compare the treatment outcomes of male and female patients with large bone defects. A total ...
Various factors influence treatment and outcomes in tibial plateau fractures. Bone defects are among them. Many materials have been proposed to address this problem: allograft, bone-cements and variou...
From December 2016 to March 2022, 45 displaced tibial plateau fractures were treated with internal fixation and augmentation using Cal-Cemex. The average age was 55.9 years. According to Schatzker cla...
The average FU was 42.8 months. CT scans taken at 1 year demonstrated a good surface osteointegration without radiolucent lines or osteolysis with good evidence of interdigitation and even bone ingrow...
Cal-Cemex combines biological features and good mechanical performances. It guarantees biocompatibility and osteoconductivity, although it is not fully reabsorbable; β-tricalciophosphate component giv...
The study suggests that Cal-Cemex is an option for tibial plateau fractures, where augmentation and support are necessary for early full weight bearing. The absence of major complications, ease of app...
Bone regeneration is driven by mesenchymal stromal cells (MSCs) via their interactions with immune cells, such as macrophages (MPs). Bone substitutes, e.g., bi-calcium phosphates (BCPs), are commonly ...
To explore the potential effect of three allogenic bone substitute configurations on the viability, adhesion, and spreading of osteoblasts in vitro....
Freeze-dried cortical bone were ground and fractions were divided into three groups with different sizes and shapes, defined as bone fiber (0.1 mm × 0.1 mm × 3 mm), bone powder (0.45-0.9 mm), and bone...
The roughness values of bone fiber, bone powder, and bone granule group were 1.878 μm (1.578-2.415 μm), 5.066 μm (3.891-6.162 μm), and 0.860 μm (0.801-1.452 μm), respectively (bone powder group compar...
All allogenic bone substitutes presented an excellent cell viability. Moreover, bone powder and bone granule group were more likely to promote cell adhesion and spreading compared to bone fiber group....
Octacalcium phosphate (OCP) has been advocated as a precursor of bone apatite crystals. Recent studies have shown that synthetic OCP exhibits highly osteoconductive properties as a bone substitute mat...
Bioactive glass has become an increasingly used treatment of cavitary bone defects in a number of orthopaedic applications. The purpose of this study was to evaluate the clinical and radiographic outc...
A single institution retrospective study was performed, which entailed review of the clinical and radiographic data of 21 patients who underwent surgical curettage and grafting of benign or low-grade ...
In the 21 patients, 11 bone tumors were latent or active (class 1) and 10 were aggressive (class 2). The mean age was 13.0±3.7 years, 6 (28.6%) were female, and the median and interquartile range for ...
Bioactive glass agents have utility for treating a broad variety of pediatric bone tumors after curettage. However, focusing these agents' use in treating latent or active subtypes of bone tumors may ...
Level III - Therapeutic....
A 66-year-old man presented with new left hip pain after total hip arthroplasty 21 years earlier. Computed tomography imaging revealed massive osteolysis involving the ileum behind the well-fixed acet...
Embolism is a rare complication of bone graft substitute injection for pelvic osteolysis. This material can extravasate from bone and deposit in the pulmonary and cerebral microcirculation....
This study aimed to improve the performance and mode of administration of a glass-reinforced hydroxyapatite synthetic bone substitute, Bonelike by Biosckin® (BL®), by association with a dextrin-based ...
Twelve participants requiring pre-molar tooth extraction and implant placement were enrolled in this study. BL® granules (250-500 µm) were administered to 6 randomized participants whereas the other 6...
The healing of defects was free of any local or systemic complications. Both treatments showed good osseointegration with no signs of adverse reaction. DEXGEL Bone exhibited increased granule resorpti...
The hydrogel-reinforced biomaterial exhibited an easier handling, a better defect filling, and benefits in implant stability....
This study validates DEXGEL Bone safety and performance as an injectable carrier of granular bone substitutes for alveolar ridge preservation....
European Databank on Medical Devices (EUDAMED) No. CIV-PT-18-01-02,705; Registo Nacional de Estudos Clínicos, RNEC, No. 30122....
